Tradestie Institutional Equity Comparison Engine
CAPR vs MPLT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CAPR Overall Edge
CAPR Captures Institutional Edge (3โ0 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Capricor Therapeutics Inc (CAPR) driven by superior Valuation, Momentum & Technical, Options & Structure. Fundamentally, CAPR trades at 78.7x Forward P/E with 0.0% operating margin (-7.9% YoY revenue) versus MPLT at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CAPR sits in CONSOLIDATION (89th %ile IV; Dealer Gamma Walls on Pro) against MPLT sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
CAPR
CAPR 78.7x vs MPLT N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin 0.0% vs 0.0% ยท YoY -7.9% vs +0.0%
Momentum & Technical Winner
CAPR
1Y +44.3% vs -51.4% ยท 52W Pos 15% vs 3%
Options & Structure Winner
CAPR
CONSOLIDATION (89th %ile IV) vs BREAKDOWN (8th %ile IV)
CAPR
NASDAQ
Capricor Therapeutics Inc
Pharmaceutical Preparations
$8.47
-11.12% 1D
Market Cap
$595.4M
1M Return
+26.23%
1Y Return
+44.29%
Forward P/E
78.7x
Unified AI Score
28.0 / 100
SELL
Tech 50.0
Fund 37.0
Flow 68.0
Mom 50.0
MPLT
US Equity
MapLight Therapeutics, Inc.
Pharmaceutical Preparations
$6.94
-4.28% 1D
Market Cap
$392.9M
1M Return
-9.87%
1Y Return
-51.4%
Forward P/E
N/M
Unified AI Score
50.4 / 100
HOLD
Tech 49.0
Fund 56.0
Flow 64.0
Mom 58.9
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CAPR +44.29%
MPLT -51.4%
Spread: +98.19 pp (CAPR Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
CAPR TTM Op. Margin: 0.0%
MPLT TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CAPR vs MPLT. Trailing 12-month operating profitability (CAPR 0.0% vs MPLT 0.0%) and valuation multiples (CAPR 78.7x vs MPLT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CAPR | MPLT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $595.4M | $392.9M | Larger Scale | CAPR |
| Trailing P/E Ratio Valuation | 78.7x | N/M | Lower Multiple | CAPR |
| Forward P/E Ratio Valuation | 78.7x | N/M | Lower Multiple | CAPR |
| Revenue Growth (YoY) Growth | -7.9% | +0.0% | Higher Growth | MPLT |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -100.5% | -111.5% | Higher ROE | CAPR |
| 52-Week Range Position Momentum | 15% ($3โ$40) | 3% ($6โ$40) | Stronger Trend | CAPR |
| Beta / 30D Volatility Risk Regime | 1.52ฮฒ ยท 152% Vol | 1.05ฮฒ ยท 78% Vol | Lower Realized Risk | MPLT |
| Unified Institutional Score Composite Signal | 28.0 / 100 (SELL) | 50.4 / 100 (HOLD) | Higher Composite | MPLT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CAPR vs MPLT Buy Guide
CAPR
CONSOLIDATION
56d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
89th %ile
IV Regime
Extreme (>80th %ile)
MPLT
BREAKDOWN
144d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CAPR nor MPLT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.